Lauren M. Sabella, Executive VP-Commercial Dvlpmnt at ACORDA THERAPEUTICS INC (ACOR), sold 4,364 shares at $24.58 ($107K) on 2012-12-04, disclosed to the SEC on 2012-12-05.
Scheduled sale ($107k) by Executive VP-Commercial Dvlpmnt under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACOR | SELL | 2018-12-21 | $210K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $192K | — | Filing → |
| ACOR | SELL | 2018-07-02 | $163K | — | Filing → |